Release Date: 18/10/21 15:55 Summary: 2021 Corporate Governance Statement Price Sensitive: No Download Document 344.61KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%